English | 简体中文 | 繁體中文 | 한국어
Share:
Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act

SAMPO PLC     STOCK EXCHANGE RELEASE         11 October 2017 at 5:20 pm

Disclosure Under Chapter 9 Section 5 of the Securities Market Act

Sampo plc (business code 0142213-3) has today received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the total number of voting rights related to Sampo A shares (ISIN: FI009003305) owned directly or through financial instruments by BlackRock, Inc. (USA tax ID 32-0174421) and its funds decreased on 10 October 2017 below five (5) per cent of all votes.

Sampo's share capital comprises 560,000,000 shares, of which 558,800,000 are A shares and 1,200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 564,800,000.

Total positions of BlackRock, Inc and its funds subject to the notification:

% of shares and voting rights (total of A)% of shares and voting rights through financial instruments (total of B)Total of both in % (A+B)
Resulting situation on the date on which threshold was crossed or reached 5.03% shares

Below 5% of voting rights
0.01% shares

Below 5% of voting rights
5.03% shares

Below 5% of voting rights
Positions of previous notification

5.07% shares

5.03% voting rights
0.07% shares

0.07% voting rights
5.14% shares

5.10% voting rights

Notified details of the resulting situation on the date on which the threshold was crossed:

A: Shares and voting rights:

Class/type of shares
ISIN code
Number of shares and voting rights% of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
FI0009003305 28,140,448 shares
below 5% of voting rights
5.03% shares
below 5% of voting rights
SUBTOTAL A 28,140,448 shares
below 5% of voting rights
5.03% shares
below 5% of voting rights

B: Financial instruments according to SMA 9:6a:

Type of financial
instrument
Expiration dateExercise/
Conversion Period
Physical or
cash settlement
Number of shares
and voting rights
% of shares and
voting rights
Securities Lent N/A N/A Physical 8,411 shares
below 5% of voting rights
0.00% shares
below 5% of voting rights
CFD N/A N/A Cash 21,536 shares
below 5% of voting rights
0.00% shares
below 5% of voting rights
SUBTOTAL B 29,947 shares
below 5% of voting rights
0.01% shares
below 5% of voting rights

SAMPO PLC

Maria Silander
Communications Manager
tel. +358 10 516 0031

Distribution:
Nasdaq Helsinki
London Stock Exchange
The principal media
Financial Supervisory Authority
www.sampo.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sampo Oyj via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Lubrizol and Danquinsa Feature High-Performing Bonding Solutions and Non-Yellowing TPUs at Fakuma 2018  
Sept 26, 2018 21:59 ET
INGREDION ANNOUNCES $60 MILLION OF INCREMENTAL PLANNED SPECIALTY CAPITAL INVESTMENTS IN ASIA-PACIFIC; Company's latest move expands its capacity for higher-value specialty ingredients  
Sept 26, 2018 21:29 ET
Lubrizol and Danquinsa Feature High-Performing Bonding Solutions and Non-Yellowing TPUs at Fakuma 2018  
Sept 26, 2018 15:56 ET
Akastor completes sale of 50% of AKOFS Offshore to form Joint Venture with Mitsui and MOL  
Sept 26, 2018 15:37 ET
INGREDION ANNOUNCES $60 MILLION OF INCREMENTAL PLANNED SPECIALTY CAPITAL INVESTMENTS IN ASIA-PACIFIC; Company's latest move expands its capacity for higher-value specialty ingredients  
Sept 26, 2018 15:03 ET
Nomination Committee; Lindab International AB (publ)  
Sept 26, 2018 15:00 ET
Vaisala's Financial Information and Annual General Meeting in 2019  
Sept 26, 2018 12:00 ET
AIR Worldwide Estimates Industry Insured Losses for Typhoon Mangkhut Will be Between USD 1 Billion and USD 2 Billion  
Sept 26, 2018 05:29 ET
FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome  
Sept 25, 2018 17:59 ET
AIR Worldwide Estimates Insured Wind and Storm Surge Losses for Hurricane Florence Will be Between USD 1.7 Billion and USD 4.6 Billion  
Sept 18, 2018 22:04 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: